Quanterix is excited to be a presenting partner at the 2nd Annual Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit 2024!

Join us in Boston from October 22nd-24th as experts in biomarker discovery, imaging, neuroscience, and regulation come together to advance biomarker assessments for neurodegenerative and neuroinflammatory therapeutics.

Stop by to meet the Quanterix team and discover how our Simoa® Technology is driving innovations in biomarker detection with unmatched sensitivity and versatility

Speaking session:

• Speaker: Kelly Miller, Ph.D., Director, Strategic Market & KOL Development
• Title: Ultrasensitive Biomarkers for Neurodegenerative Disease: Clinical and Diagnostic Advances
• Date/Time: October 23, 2024, 11:15am